ED
EHC icon

Exane Derivatives’s Encompass Health EHC Stock Holding History

Exane Derivatives’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$711K Sell
15,955
-4,425
-22% -$227K 0.41% 55
2022
Q1 		$1.15M Sell
20,380
-144
-0.7% -$7.52K 0.32% 73
2021
Q4 		$1.07M Buy
20,524
+17,162
+510% +$885K 0.26% 83
2021
Q3 		$201K Sell
3,362
-236
-7% -$14.8K 0.05% 390
2021
Q2 		$230K Buy
3,598
+2,262
+169% +$151K 0.05% 363
2021
Q1 		$87.1K Sell
1,336
-1,810
-58% -$118K 0.02% 440
2020
Q4 		$207K Buy
3,146
+1,747
+125% +$103K 0.06% 306
2020
Q3 		$72.3K Hold
1,399
– – 0.02% 343
2020
Q2 		$68.9K Hold
1,399
– – 0.02% 332
2020
Q1 		$71.3K Sell
1,399
-202
-13% -$11.6K 0.02% 323
2019
Q4 		$98.7K Hold
1,601
– – 0.02% 316
2019
Q3 		$80.6K Hold
1,601
– – 0.01% 335
2019
Q2 		$80.7K Hold
1,601
– – 0.01% 354
2019
Q1 		$74.4K Buy
1,601
+876
+121% +$44.4K 0.01% 321
2018
Q4 		$35.6K Buy
+725
New +$41.2K 0.01% 394

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's EHC Position: Q2 2022 in Review

Exane Derivatives reduced its Encompass Health (EHC) stake by 22% in Q2 2022, selling an estimated $227K and leaving 15,955 shares worth $711K. The position accounts for 0.41% of the portfolio, ranked #55.

Exane Derivatives first reported a position in EHC in Q4 2018 and has held it in 15 quarters since. The position peaked at $1.15M in Q1 2022. 395 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

  • Exane Derivatives held 15,955 shares of Encompass Health worth $711K as of Q2 2022.
  • Exane Derivatives sold 4,425 Encompass Health shares in Q2 2022, an estimated $227K.
  • Encompass Health made up 0.41% of Exane Derivatives's portfolio in Q2 2022, its #55 holding.
  • Exane Derivatives first reported a position in Encompass Health in Q4 2018 and has held it in 15 quarters since.
  • Exane Derivatives's Encompass Health position peaked at $1.15M in Q1 2022.
  • 395 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.